This interactive 90-minute training provides HBV prescribers an opportunity to apply their knowledge and skills to practical case studies spanning diagnosis to treatment initiation and ongoing monitoring.
Case scenarios are developed by ASHM clinical advisors or local experts to meet the identified learning needs of ASHM’s HBV prescribers, which vary from each State and Territory.
Attendees are also encouraged to submit their own cases for discussion. You can receive a second HBV CPD point by submitting and discussing one of your own de-identified patient cases on the night. Please send any cases to [email protected] by 6 February 2025.
Date, Time & Platform:
Date: Tuesday, 24 February 2026
Time: 6:30pm – 8:00pm (AEST)
Platform: Online via Teams
Target Audience:
Queensland Hepatitis B s100 Prescribers.
Speakers/Facilitators:
TBC
Learning Outcomes:
- Plan guideline-based monitoring for patients with chronic hepatitis B.
- Evaluate chronic hepatitis B patients’ suitability for antiviral treatment.
- Select and prescribe appropriate first-line antiviral medication for patients with chronic hepatitis B.
Endorsement and CPD:
RACGP: This course has been approved as a CPD activity by RACGP for the 2023-2025 triennium. Educational Activities: 1.5. RACGP Activity Number: 462332
ACCRM: This course has been approved by ACRRM as an accredited activity. Allocated PDP units: 1.5 Educational hours and 4 additional CPD requirements.
ACNP: This activity is endorsed by the Australian College of Nurse Practitioners (ACNP) for 1.5 CPD hours.
Funding:
This course is funded by Queensland Health.
